Group 1 - The core idea of the article is the launch of "Internet + Nursing Services" by the Second People's Hospital of Loudi City, which extends professional nursing care from hospitals to patients' homes starting December 20, 2025 [1][3] - The service has been upgraded to a medical and nursing joint team, which recently provided care to an elderly male patient in Shanshan Community, receiving high praise from the patient's family for the professional catheter replacement service [1][3] - The nursing team conducted a comprehensive assessment of the patient's health status, catheter condition, and home environment before performing the procedure under strict sterile conditions [1] Group 2 - The family of the patient expressed gratitude for the home service, highlighting the convenience it provided, as previous hospital visits were burdensome for both the patient and the family [3] - The service not only addressed the patient's immediate needs but also embodied the core philosophy of "Internet + Nursing Services," which emphasizes professional care at home and warmth in service [3] - The hospital plans to further deepen the connotation of "Internet + Nursing Services" and expand the service range to ensure more immobile patients can enjoy safe, high-quality, continuous hospital-level professional nursing at home [3]

Group 1 - The core viewpoint of the news is the performance and financial details of Sanbo Brain Science Hospital Management Group Co., Ltd, which saw a stock price increase of 5.12% to 80.28 CNY per share, with a trading volume of 601 million CNY and a market capitalization of 16.537 billion CNY [1] - The company, established on November 25, 2003, and listed on May 5, 2023, primarily provides medical services, with revenue composition as follows: 74.35% from medical services, 25.02% from pharmaceuticals, 0.39% from other sources, and 0.24% from supply chain [1] Group 2 - From the perspective of the top ten circulating shareholders, Huabao Fund's Huabao CSI Medical ETF (512170) reduced its holdings by 749,300 shares in the third quarter, now holding 4.0556 million shares, which accounts for 2.52% of the circulating shares [2] - The estimated floating profit from this reduction is approximately 15.8575 million CNY [2] - The Huabao CSI Medical ETF was established on May 20, 2019, with a current scale of 25.263 billion CNY, yielding 4.83% this year, ranking 3398 out of 5551 in its category, and 14.55% over the past year, ranking 3650 out of 4285 [2] Group 3 - The fund manager of Huabao CSI Medical ETF is Hu Jie, who has a cumulative tenure of 13 years and 109 days, managing total assets of 101.358 billion CNY [3] - During Hu Jie's tenure, the best fund return was 161.34%, while the worst was -98.01% [3]

Group 1 - The core viewpoint of the article is that Zhuozheng Medical (2677.HK) is launching its IPO with a strong financial performance, contrasting with the industry's challenges [1] - The IPO will take place from January 29 to February 3, 2026, with a global offering of 4.75 million shares priced between HKD 57.7 and HKD 66.6 [1] - Zhuozheng Medical has achieved revenue growth from CNY 470 million in 2022 to CNY 690 million in 2023, and projected CNY 960 million in 2024, with a compound annual growth rate (CAGR) of 42.2% [1] - The company's gross profit has increased significantly, from CNY 43.98 million in 2022 to CNY 130 million in 2023, and projected CNY 230 million in 2024, with a CAGR of 126.7% [1] - Zhuozheng Medical is expected to turn profitable in 2024, with adjusted net profits improving from a loss of CNY 1.23 billion in 2022 to a profit of CNY 10.7 million in 2024 [1] - The net cash flow from operating activities has shown steady growth, increasing from CNY 6.86 million in 2022 to CNY 12.4 million in 2023, and projected CNY 17.1 million in 2024 [1] Group 2 - Notable cornerstone investors in the IPO include leading third-party testing company Kingmed Diagnostics and He Xiaopeng, founder of Xpeng Motors, enhancing Zhuozheng Medical's IPO [2] - Several Tencent-affiliated listed companies are participating in the cornerstone investment, including Minglue Technology, Weimeng Group, Kuro Game, and Shouhui Group [2]

公司引入Health Vision Hong Kong Limited、广州金域医学检验集团股份有限公司、明略科技、Galaxy Dynasty Limited等基石投资者，将以发售价共认购数量下限约134.95万股可购买发售的股份。 卓正医疗(02677.HK)发布公告，公司拟全球发售475.00万股股份，其中香港发售股份47.50万股，国际发 售股份427.50万股，另有71.25万股超额配股权。招股日期为1月29日至2月3日，最高发售价66.60港元， 每手买卖单位50股，入场费约3363.58港元。 全球发售预计募资总额为2.95亿港元，募资净额2.19亿港元，募资用途为用于通过打造一个医疗人工智 能应用的专业人才库、与领先的科研机构及公司开展战略合作及外部采购；用于升级现有医疗服务机构 及设立新医疗服务机构；用于在适当机会出现时收购一线城市及新一线城市中业绩良好的医疗服务机 构；用作营运资金及其他一般公司用途。 公司2022年度、2023年度、2024年度截至12月31日止，净利润分别为-2.15亿元、-3.51亿元、8380.50万 元，同比变动幅度为14.13%、-62.73%、123.90%。 ...

Industry Overview - The pharmaceutical and biotechnology sector experienced a decline of 0.39% last week, ranking 27th among 31 primary industries in the Shenwan index. The CSI 300 index fell by 0.62%, indicating that the pharmaceutical sector outperformed the CSI 300 by 0.23 percentage points [3] - The medical services sub-sector reported a drop of 2.17%, while other sub-sectors such as traditional Chinese medicine and medical commercial showed positive growth [3] Company Performance - Notable performers in the medical services sector included: - Nuohe Zhiyuan (+11.5%) - Xin Licheng (+9.4%) - Dian Diagnostics (+8.2%) - ST Zhongzhu (+7.1%) - Guangzheng Eye Hospital (+6.2%) - Underperformers included: - Boteng Co. (-6.9%) - Chengda Pharmaceutical (-6.6%) - WuXi AppTec (-6.4%) - Mediso (-4.8%) - Chengdu Xian Dao (-4.5%) [4] Financial Metrics - The medical services sector's Price-to-Earnings (PE) ratio is 35.30X, with a one-year maximum of 41.13X and a minimum of 28.46X. The Price-to-Book (PB) ratio stands at 3.58X, with a one-year maximum of 4.00X and a minimum of 2.48X. The PE ratio decreased by 0.85X and the PB ratio decreased by 0.09X compared to the previous week [6] CXO Industry Insights - The J.P. Morgan Healthcare Conference highlighted an optimistic outlook for the CXO industry, with companies like WuXi AppTec and WuXi Biologics showcasing strong growth prospects. The industry is transitioning from scale competition to value competition, focusing on advanced technologies and global supply chains. Notably, ADC CDMO is expected to drive significant revenue growth [7] Investment Recommendations - The report maintains a "buy" rating for the medical services sector, emphasizing the importance of innovation in the pharmaceutical supply chain. Key areas of focus include: - High growth: Companies involved in ADC CDMO and peptide CDMO, such as WuXi AppTec and Hao Yuan Pharmaceutical - Expected improvement: Third-party testing laboratories and consumer healthcare sectors, particularly in ophthalmology and dentistry, such as Aier Eye Hospital and Dian Diagnostics [8]

Core Viewpoint - The establishment of the "Love Mutual Assistance Shared Cabin" for rehabilitation aids in Handan City aims to enhance resource utilization and improve public welfare for patients with disabilities [3] Group 1: Initiative Overview - The Handan Municipal Health Commission, in collaboration with the Municipal Disabled Persons' Federation and the Red Cross Society, is launching a pilot project to create a specialized and standardized rehabilitation aid sharing center [3] - The initiative focuses on integrating idle rehabilitation aids, establishing management systems for registration, assessment, and classification, and ensuring strict cleaning and safety protocols [3] Group 2: Hospital Involvement - Wukuang Handan-Xing Workers' General Hospital has actively responded by forming a working group to establish the "Love Mutual Assistance Shared Cabin" and has initiated a donation campaign [3] - The hospital's efforts were recognized during a verification visit by officials from the health commission, disabled persons' federation, and Red Cross Society, marking the official launch of the shared cabin [3] Group 3: Community Impact - The ongoing donation campaign for rehabilitation aids is expected to benefit a wide range of citizens, promoting resource recycling and enhancing the warmth of public services [3]

该院晶格放疗的成功实施，是坚持肿瘤规范化治疗、推动医疗技术创新的重要成果。未来，肿瘤科将不 断引进开展新项目、新技术，为更多晚期肿瘤患者量身打造专属治疗方案，以精准医疗为生命护航。 晚期癌症患者因肿瘤迅速生长，体积较大，压迫、浸润周围器官，传统治疗手段治疗效果不佳，治疗之 路一度陷入僵局。肿瘤科积极探索新疗法，一致认为晚期直肠癌肝转移，肿块巨大时，传统治疗往往面 临两难选择，加大剂量可能损伤健康肝组织，降低剂量又难以遏制肿瘤进展。而空间放疗（晶格放疗） 是一种前沿的空间分割放疗技术，不同于传统放疗的"均匀覆盖"模式，晶格放疗在肿瘤内部构建成一个 个立体的高剂量晶格区域，更像是精准安排的"定点爆破"。 这些"能量晶格"既能形成叠加效应，对肿瘤细胞产生强效杀伤作用，又能在彼此之间保留低剂量区域， 为周围正常组织提供保护通道，发挥"精准杀伤+器官保护"的双重优势。对于肿瘤体积超过5厘米的患 者，能够克服常规放疗的剂量瓶颈。 空间放疗作为打破困局的最优选择，该院肿瘤科决定向"精准放疗"发起冲击。治疗方案确定后，刘元照 教授团队从患者的定位、勾画靶区、计划制定、验证及实施的各个环节全程跟踪指导，确保每一道射线 都精准命 ...

格隆汇1月29日丨卓正医疗(02677.HK)发布公告，公司拟全球发售475万股股份，中国香港发售股份47.5 万股，国际发售股份427.5万股(以上可予重新分配及视乎超额配股权行使与否而定)；2026年1月29日至2 月3日招股，预期定价日为2月4日；发售价将为每股发售股份57.70-66.60港元，每手买卖单位将为50 股，海通国际及浦银国际为联席保荐人；预期H股将于2026年2月6日开始于联交所买卖。 ...

香港交易及結算所有限公司、香港聯合交易所有限公司（「聯交所」）及香港中央結算有限公司 （「香港結算」）對本公告的內容概不負責，對其準確性或完整性亦不發表任何聲明，並明確表 示概不就因本公告全部或任何部分內容而產生或因依賴該等內容而引致的任何損失承擔任何責 任。 潛在投資者應注意，為支持股份價格而採取的穩定價格行動的時間不得超過穩定價格期間， 其將於上市日期開始並預期於2026年3月5日（即遞交香港公開發售申請截止日期後第30日）屆 滿。在該日期之後，不得採取進一步的穩定價格行動，對股份的需求可能會下跌，從而導致股 份的價格下跌。 倘於上市日期上午八時正前發生若干事件，則聯席整體協調人（為其本身及代表包銷商）可終止 香港包銷商根據香港包銷協議認購及促使認購人認購香港發售股份的責任。有關理由載於招股 章程「包銷」一節。 閣下務請參閱該節以了解詳情。 1 Distinct Healthcare Holdings Limited 卓正醫療控股有限公司 （於開曼群島註冊成立的有限公司） 本公告不得直接或間接於或向美國（包括其領土及屬地、美國任何州以及哥倫比亞特區）發佈、 刊發、派發。本公告並不且無意在美國境內或任何其他 ...

Core Viewpoint - The article discusses the increase in pediatric patients seeking eye and dental treatments during the winter vacation period, emphasizing the importance of early appointments and preventive care to avoid complications and ensure timely treatment [3][4][11]. Eye Care Industry - The Tianjin Eye Hospital has seen a significant rise in pediatric consultations, particularly in the pediatric ophthalmology department, which is experiencing a peak in strabismus surgeries during the winter break [5][6]. - The hospital anticipates performing over 6,000 strabismus surgeries in 2025, with 85% of inpatients coming from outside the region, highlighting its status as a leading institution for strabismus treatment [6]. - The hospital has implemented measures to improve patient experience, including weekend and night clinics, and a dedicated optical clinic to manage non-surgical cases [8]. - Early detection and treatment of strabismus are crucial, as untreated cases can lead to irreversible damage to visual function [7][8]. Dental Care Industry - The Tianjin Dental Hospital has entered a peak period for pediatric dental appointments, with high demand for orthodontic and pediatric services [11][12]. - Parents are advised to schedule dental check-ups early during the vacation, as many treatments require multiple visits and can become more complex if delayed [12][13]. - The hospital emphasizes the importance of maintaining good oral hygiene, especially during the holiday season when children's routines may be disrupted [13]. - The risk of dental injuries is heightened during the winter break, and parents are encouraged to take preventive measures, such as using mouthguards during sports [14].